Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
0.5950
-0.0050 (-0.83%)
Processa Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for patients with unmet medical needs
The company primarily concentrates on advancing treatments for various cancer types and gastrointestinal disorders by utilizing its proprietary drug candidates. Through rigorous research and clinical trials, Processa aims to improve patient outcomes and enhance the quality of life for those affected by serious health conditions. Its strategic approach includes leveraging repurposed existing therapies as well as developing novel compounds, highlighting its commitment to addressing significant healthcare challenges.
Frequently Asked Questions
Is Processa Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Processa Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Processa Pharmaceuticals, Inc. - Common Stock trade on?
Processa Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Processa Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Processa Pharmaceuticals, Inc. - Common Stock is PCSA on the Nasdaq Stock Market
What is the current price of Processa Pharmaceuticals, Inc. - Common Stock?
The current price of Processa Pharmaceuticals, Inc. - Common Stock is 0.5950
When was Processa Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Processa Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on February 6th, 2025
What is the market capitalization of Processa Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Processa Pharmaceuticals, Inc. - Common Stock is 1.94M
How many shares of Processa Pharmaceuticals, Inc. - Common Stock are outstanding?
Processa Pharmaceuticals, Inc. - Common Stock has 3.27M shares outstanding.